Related Experiment Video
Updated: May 7, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
The clinical spectrum of paediatric NF2- related schwannomatosis
Dorothy Halliday1, Lucy Hanington2,3
1Department of Clinical Genetics, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Dorothy.Halliday@ouh.nhs.uk.
Abstract:
The clinical spectrum of paediatric NF2-SWN is broad and differs from that seen in the cohort of patients presenting over age 30, where symptoms typically relate to enlarging schwannoma, meningioma or ependymoma. Paediatric cases tend to have a multisystemic presentation with a high tumour burden and significant physical and psychological morbidity. Visual impairment as well as dermatological and non-tumour neurological features are common. Genetic testing characteristically identifies a germline pathogenic variant (often truncating) in the NF2 gene. This review explores the spectrum of clinical disease that arises in NF2-SWN when presenting in childhood.

